(Q38113138)

29 August 2017

title

The blockade of the neurotransmitter release apparatus by botulinum neurotoxins (English)

1 reference

29 August 2017

1 reference

1

Sergio Pantano

1 reference

29 August 2017

2

Cesare Montecucco

1 reference

29 August 2017

publication date

11 June 2013

1 reference

Cellular and Molecular Life Sciences

29 August 2017

published in

1 reference

29 August 2017

volume

71

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

793-811

1 reference

Central effects of tetanus and botulinum neurotoxins

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Molecular anatomy of a trafficking organelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Synaptic vesicle exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Molecular machines governing exocytosis of synaptic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinal neurotoxins: revival of an old killer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Expanding use of botulinum toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Clinical applications of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Sequence homology and structural analysis of the clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Cell entry strategy of clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Bacterial protein toxins penetrate cells via a four-step mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structure and function of tetanus and botulinum neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum neurotoxin: a marvel of protein design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Molecular structures and functional relationships in clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Clostridial neurotoxins: new tools for dissecting exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

How botulinum and tetanus neurotoxins block neurotransmitter release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNAP receptors implicated in vesicle targeting and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Syntaxin requirement for Ca2+-triggered exocytosis in neurons and endocrine cells demonstrated with an engineered neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Engineering botulinum neurotoxin to extend therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Identification of a Unique Ganglioside Binding Loop within Botulinum Neurotoxins C and D-SA,

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

v-SNARE composition distinguishes synaptic vesicle pools.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Vti1a identifies a vesicle pool that preferentially recycles at rest and maintains spontaneous neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The role of non-canonical SNAREs in synaptic vesicle recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Substrate recognition strategy for botulinum neurotoxin serotype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Receptor and substrate interactions of clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Proteolysis of synthetic peptides by type A botulinum neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Unique substrate recognition by botulinum neurotoxins serotypes A and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

2.3 A crystal structure of tetanus neurotoxin light chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structural analysis of the catalytic domain of tetanus neurotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Insights into the different catalytic activities of Clostridium neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Multiple Pocket Recognition of SNAP25 by Botulinum Neurotoxin Serotype E

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Catalytic properties of botulinum neurotoxin subtypes A3 and A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Plasma membrane localization signals in the light chain of botulinum neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Observations on the action of type A botulinum toxin on frog neuromuscular junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212-->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Role of metals in the biological activity of Clostridium botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Metal substitution of tetanus neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Substrate recognition of anthrax lethal factor examined by combinatorial and pre-steady-state kinetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum toxin type F for treatment of dystonia: long-term experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Comparison of neuromuscular blockade and recovery with botulinum toxins A and F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A single amino acid near the C terminus of the synaptosomeassociated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

High affinity interaction of syntaxin and SNAP-25 on the plasma membrane is abolished by botulinum toxin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Uptake of botulinum neurotoxin into cultured neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNARE complexes and neuroexocytosis: how many, how close?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Self-assembly of SNARE fusion proteins into star-shaped oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Membrane fusion: grappling with SNARE and SM proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Mechanisms of membrane fusion: disparate players and common principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Conflicting views on the membrane fusion machinery and the fusion pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structural organization of the synaptic exocytosis core complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structure of human synaptotagmin 1 C2AB in the absence of Ca2+ reveals a novel domain association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Calcium control of neurotransmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Phosphoinositides in cell regulation and membrane dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Lipid dynamics in exocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Molecular mechanism of the synaptotagmin–SNARE interaction in Ca2+-triggered vesicle fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Synaptotagmin 1 and SNAREs form a complex that is structurally heterogeneous

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The calcium-dependent and calcium-independent membrane binding of synaptotagmin 1: two modes of C2B binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Single-molecule FRET-derived model of the synaptotagmin 1-SNARE fusion complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Ca(2+)-independent syntaxin binding to the C(2)B effector region of synaptotagmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A quaternary SNARE-synaptotagmin-Ca2+-phospholipid complex in neurotransmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Ca2+-dependent synaptotagmin binding to SNAP-25 is essential for Ca2+-triggered exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Conserved prefusion protein assembly in regulated exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Solution single-vesicle assay reveals PIP2-mediated sequential actions of synaptotagmin-1 on SNAREs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Alternative zippering as an on-off switch for SNARE-mediated fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A clamping mechanism involved in SNARE-dependent exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin and Ca2+ stimulate SNARE-mediated membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The carboxy-terminal domain of complexin I stimulates liposome fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin controls the force transfer from SNARE complexes to membranes in fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Distinct domains of complexin I differentially regulate neurotransmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The synaptic SNARE complex is a parallel four-stranded helical bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The presynaptic active zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Membrane fusion intermediates via directional and full assembly of the SNARE complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin cross-links prefusion SNAREs into a zigzag array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A conformational switch in complexin is required for synaptotagmin to trigger synaptic fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin arrests a pool of docked vesicles for fast Ca2+-dependent release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin activates and clamps SNAREpins by a common mechanism involving an intermediate energetic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexin maintains vesicles in the primed state in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Complexins facilitate neurotransmitter release at excitatory and inhibitory synapses in mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Three-dimensional structure of the complexin/SNARE complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Mechanics of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Understanding synapses: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Distinct initial SNARE configurations underlying the diversity of exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Currents through the fusion pore that forms during exocytosis of a secretory vesicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Subnanometer fusion pores in spontaneous exocytosis of peptidergic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNARE requirements en route to exocytosis: from many to few.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

One SNARE complex is sufficient for membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Three SNARE complexes cooperate to mediate membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Fast vesicle fusion in living cells requires at least three SNARE complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Supramolecular SNARE assembly precedes hemifusion in SNARE-mediated membrane fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNARE proteins: one to fuse and three to keep the nascent fusion pore open

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A fast, single-vesicle fusion assay mimics physiological SNARE requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Single vesicle millisecond fusion kinetics reveals number of SNARE complexes optimal for fast SNARE-mediated membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A single vesicle-vesicle fusion assay for in vitro studies of SNAREs and accessory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A transient N-terminal interaction of SNAP-25 and syntaxin nucleates SNARE assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Membrane protein sequestering by ionic protein-lipid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Single secretory granules of live cells recruit syntaxin-1 and synaptosomal associated protein 25 (SNAP-25) in large copy numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Discrimination between docking and fusion of liposomes reconstituted with neuronal SNARE-proteins using FCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The alpha-helix dipole and the properties of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Crystal structure of a synthetic triple-stranded alpha-helical bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Destabilization of an alpha-helix-bundle protein by helix dipoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The reserve pool of synaptic vesicles acts as a buffer for proteins involved in synaptic vesicle recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Synaptic vesicles position complexin to block spontaneous fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A role of complexin-lipid interactions in membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Evidence for a radial SNARE super-complex mediating neurotransmitter release at the Drosophila neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Arg206 of SNAP-25 is essential for neuroexocytosis at the Drosophila melanogaster neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Quantitative analysis of the native presynaptic cytomatrix by cryoelectron tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Presynaptic calcium and control of vesicle fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

A comparison between exocytic control mechanisms in adrenal chromaffin cells and a glutamatergic synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

The architecture of active zone material at the frog's neuromuscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Recombinant and Truncated Tetanus Neurotoxin Light Chain: Cloning, Expression, Purification, and Proteolytic Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Mixing Atomistic and Coarse Grain Solvation Models for MD Simulations: Let WT4 Handle the Bulk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

v-SNARE Actions during Ca2+-Triggered Exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Neurotransmission and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

SNARE motif and neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1380-7

Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc

21 January 2018

1 reference

12 December 2020

Fusion complex formation protects synaptobrevin against proteolysis by tetanus toxin light chain

1 reference

12 December 2020

Proteolysis: from the lysosome to ubiquitin and the proteasome

1 reference

12 December 2020

Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins

1 reference

12 December 2020

Neurotoxins affecting neuroexocytosis

1 reference

12 December 2020

Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin

1 reference

12 December 2020

Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design

1 reference

12 December 2020

N- to C-Terminal SNARE Complex Assembly Promotes Rapid Membrane Fusion

1 reference

12 December 2020

Bacterial toxins: a table of lethal amounts

1 reference

12 December 2020

Substrate residues N-terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity

1 reference

12 December 2020

Persistence of botulinum neurotoxin action in cultured spinal cord cells

1 reference

12 December 2020

VAMP subfamilies identified by specific R-SNARE motifs

1 reference

12 December 2020

VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes

1 reference

12 December 2020

Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain

1 reference

12 December 2020

Energetics and dynamics of SNAREpin folding across lipid bilayers

1 reference

12 December 2020

Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light chain

1 reference

12 December 2020

Helical extension of the neuronal SNARE complex into the membrane

1 reference

12 December 2020

Persistence of Botulinum neurotoxin inactivation of nerve function

1 reference

12 December 2020

Truncated SNAP-25 (1-197), like botulinum neurotoxin A, can inhibit insulin secretion from HIT-T15 insulinoma cells

1 reference

12 December 2020

Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis

1 reference

12 December 2020

Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.

1 reference

12 December 2020

Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F

1 reference

12 December 2020

Metal Substitutions and Inhibition of Thermolysin: Spectra of the Cobalt Enzyme

1 reference

12 December 2020

Structure and dynamics of nano-sized raft-like domains on the plasma membrane

1 reference

12 December 2020

The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F

1 reference

12 December 2020

Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc

1 reference

12 December 2020

Human response to botulinum toxin injection: type B compared with type A

1 reference

12 December 2020

Genetic Diversity Within Clostridium botulinum Serotypes, Botulinum Neurotoxin Gene Clusters and Toxin Subtypes

1 reference

12 December 2020

Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity

1 reference

12 December 2020

Recovery from botulinum neurotoxin poisoning in vivo

1 reference

12 December 2020

Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B

1 reference

12 December 2020

Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction

1 reference

12 December 2020

Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study

1 reference

12 December 2020

Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells

1 reference

12 December 2020

1 reference

12 December 2020

Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly

1 reference

12 December 2020

Morphologically docked synaptic vesicles are reduced in synaptotagmin mutants of Drosophila.

1 reference

12 December 2020

Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning

1 reference

12 December 2020

SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils

1 reference

12 December 2020

Intracellular calcium dependence of transmitter release rates at a fast central synapse

1 reference

12 December 2020

Possession, use, and transfer of select agents and toxins; biennial review. Final rule

1 reference

12 December 2020

10.1007/S00018-013-1380-7

Identifiers

DOI

1 reference

29 August 2017

1 reference